T1	Participants 297 306	patients.
T2	Participants 336 344	patients
T3	Participants 361 392	a total of 247 febrile episodes
T4	Participants 848 879	All 247 episodes were evaluable
T5	Participants 1840 1848	patients
T6	Participants 1966 1974	patients
